Physicians Ask: Are School 'Physicals' Adequate after COVID Jab?
TUCSON, Ariz., July 15, 2021 /PRNewswire/ -- On June 23, the Advisory Committee on Immunization Practices (ACIP) had an emergency meeting because of reports of myocarditis (heart inflammation) after COVID-19 shots. There were about 600 cases reported at that time; the number is now more than 1,200. The Centers for Disease Control and Prevention (CDC) concluded that this effect is "extremely rare" and "usually mild." It will continue to monitor, but still recommends the jab for persons age 12 and over.
Hundreds of colleges are nonetheless still mandating a COVID jab to return to campus. The Association of American Physicians and Surgeons (AAPS) urges colleges, parents, students, and physicians to consider the following:
School physicals are often perfunctory and do not include CDC-recommended tests for myocarditis: electrocardiogram (ECG), troponin levels, or measures of inflammation such as C-reactive protein (CRP) or erythrocyte sedimentation rate (ESR). They also do not generally include echocardiography or magnetic resonance imaging (MRI).
Treatment for myocarditis includes anti-inflammatory medications, renin-angiotensin inhibitors, beta-blockers, colchicine, abstinence from alcohol, and restriction of physical activity for three to six months.
There have been no large studies that screened asymptomatic vaccine recipients for these effects, which were not part of the safety trials.
AAPS recommends that students be made aware of these facts. They should ask for an official college policy regarding COVID mandates, the person or persons responsible for it, and any provisions for screening, treatment, or compensation of students or employees mandated to receive these products who experience myocarditis or pericarditis. This is especially critical for those planning to engage in competitive athletics.
Omni Quality Living ("Omni"), a portfolio business of The Hillcore Group, a leader in long-term care and senior living, is pleased to announce effective July 2nd, 2024, it has assumed the management of five high-quality long-term care homes located...
The Prime Minister, Justin Trudeau, today announced the reappointment of Dr. Mona Nemer as Canada's Chief Science Advisor for a term of three years, effective September 25, 2024.
A distinguished medical researcher, Dr. Nemer has served as Canada's...
The "TechVision50: Top 50 Advanced and Emerging Technologies" report has been added to ResearchAndMarkets.com's offering.
TechVision50 is a guide of the 50 greatest opportunities in Advanced Technologies and Materials at the mid-point of 2024. This...
The "Viral Vector Collaboration and Licensing Deals 2016-2024" report has been added to ResearchAndMarkets.com's offering.
Viral Vector Collaboration and Licensing Deals provides a comprehensive understanding and unprecedented access to the viral...
The "The Worldwide Market for Clinical Laboratory Services, 9th Edition" report has been added to ResearchAndMarkets.com's offering.
Stay ahead with insights into demographic trends, disease trends, new developments, company performance, mergers...
The "Drug Delivery Collaboration and Licensing Deals 2016-2024" report has been added to ResearchAndMarkets.com's offering.
Drug Delivery Collaboration and Licensing Deals provides a comprehensive understanding and unprecedented access to the drug...